MINNEAPOLIS -(Dow Jones)- Medtronic Inc. ( MDT) filed a premarket approval, or PMA, module for its Endeavor drug-eluting coronary stent, as the company starts the process to gain Food and Drug Administration approval for the system.
http://c.moreover.com/click/here.pl?r404598617
http://c.moreover.com/click/here.pl?r404598617